Pyoderma gangrenosum and Psoriasis

Summary:

Psoriasis is found among people with Pyoderma gangrenosum, especially for people who are female, 50-59 old.

The study analyzes which people have Psoriasis with Pyoderma gangrenosum. It is created by eHealthMe based on reports of 16 people who have Pyoderma gangrenosum from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pyoderma gangrenosum?

Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance) is found to be associated with 305 drugs and 348 conditions by eHealthMe. Check the latest studies of Pyoderma gangrenosum.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,474 drugs and 1,695 conditions by eHealthMe. Check the latest studies of Psoriasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

16 people who have Pyoderma Gangrenosum and Psoriasis are studied.

Would you have Psoriasis when you have Pyoderma gangrenosum?

Gender of people who have Pyoderma Gangrenosum and experienced Psoriasis *:

  • female: 73.33 %
  • male: 26.67 %

Age of people who have Pyoderma Gangrenosum and experienced Psoriasis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 14.29 %
  • 50-59: 57.14 %
  • 60+: 14.29 %

Common co-existing conditions for these people *:

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 25.00%
  2. High Blood Pressure: 3 people, 18.75%
  3. Monoclonal Gammopathy: 3 people, 18.75%
  4. Arthropathy: 2 people, 12.50%
  5. Depression: 2 people, 12.50%
  6. Irritable Bowel Syndrome: 2 people, 12.50%
  7. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 12.50%
  8. Migraine (headache): 2 people, 12.50%
  9. Sleep Walking (walking during sleep): 2 people, 12.50%
  10. Neck Pain: 2 people, 12.50%

Common drugs taken by these people *:

  1. Remicade: 5 people, 31.25%
  2. Amlodipine: 3 people, 18.75%
  3. Metformin: 3 people, 18.75%
  4. Simponi: 3 people, 18.75%
  5. Flagyl: 3 people, 18.75%
  6. Baby Aspirin: 2 people, 12.50%
  7. Clonazepam: 2 people, 12.50%
  8. Cosentyx: 2 people, 12.50%
  9. Cyclosporine: 2 people, 12.50%
  10. Dapsone: 2 people, 12.50%

Common symptoms for these people *:

  1. Neuropathy Peripheral (surface nerve damage): 4 people, 25.00%
  2. Abdominal Pain: 3 people, 18.75%
  3. Ocular Hyperaemia (an abnormally large amount of blood in eye): 3 people, 18.75%
  4. Eye Irritation: 3 people, 18.75%
  5. Adverse Drug Reaction: 2 people, 12.50%
  6. Anaemia (lack of blood): 2 people, 12.50%
  7. Gait Disturbance: 2 people, 12.50%
  8. Haematocrit Decreased: 2 people, 12.50%
  9. Haemoglobin Decreased: 2 people, 12.50%
  10. Joint Pain: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Psoriasis?

- Check whether Psoriasis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Psoriasis:

All the conditions that are associated with Psoriasis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Psoriasis and Pyoderma gangrenosum, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: